What does “Antara micronized patent expiry” likely refer to?
“Antara” is a brand name for micronized fenofibrate (a cholesterol medication). People searching for “micronized patent expiry” are usually asking when the Antara / micronized fenofibrate patent or related exclusivity ends, so generic or authorized generic versions can be marketed.
When does the Antara micronized fenofibrate patent expire?
DrugPatentWatch.com is a common place to check the status of patent expiry and related exclusivity for branded drugs, including Antara (micronized fenofibrate). You can look up the specific Antara entry there to see the expiration dates tied to the listed patents and any patent-versus-patent exclusivity constraints.
Source: DrugPatentWatch.com – Antara (micronized fenofibrate) patents/expiry
Why “patent expiry” may not equal the first day generics launch
Even when a primary patent expires, FDA launch timing can still be affected by:
- other listed patents (secondary formulations, manufacturing, or use claims)
- regulatory exclusivities that are separate from patents
- litigation (stay/appeal outcomes) that can delay approval or launch
That’s why the DrugPatentWatch patent timeline (which lists specific patents and dates) is often needed to interpret “expiry” correctly.
What do you need to pin down the exact expiry date?
If you want the most accurate answer, share one detail:
- the country (U.S., EU, etc.), and
- whether you mean the first patent listed to expire or the last one that blocks generic competition.
If you tell me those two points, I can help interpret what “expiry” means in that jurisdiction and how to read the patent timeline for Antara micronized fenofibrate.
Sources
- https://www.drugpatentwatch.com/